Icad Inc Stock Today
| ICAD Stock | USD 1.54 0.01 0.65% |
Performance1 of 100
| Odds Of DistressLess than 9
|
Icad is trading at 1.54 as of the 22nd of November 2024, a 0.65 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.49. Icad has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for icad inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 3rd of December 1986 | Category Healthcare | Classification Health Care |
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. The company has 26.35 M outstanding shares of which 249.09 K shares are currently shorted by private and institutional investors with about 1.51 trading days to cover. More on icad inc
Moving together with Icad Stock
Moving against Icad Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Icad Stock Highlights
| CEO President | Dana Brown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, SBF 120, SBF 120 Gross, CAC All Shares, Health Care, Health Care Technology, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsIcad can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Icad's financial leverage. It provides some insight into what part of Icad's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
icad inc (ICAD) is traded on NASDAQ Exchange in USA. It is located in 98 Spit Brook Road, Nashua, NH, United States, 03062 and employs 67 people. Icad is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 40.72 M. icad inc conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 26.35 M outstanding shares of which 249.09 K shares are currently shorted by private and institutional investors with about 1.51 trading days to cover.
icad inc currently holds about 27.18 M in cash with (4.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.07.
Check Icad Probability Of Bankruptcy
Ownership Allocationicad inc has a total of 26.35 Million outstanding shares. Icad retains 5.63 (percent) of its outstanding shares held by insiders and 27.15 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Icad Ownership Details
Icad Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Essex, Llc | 2024-09-30 | 138 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 102.4 K | |
| Bridgeway Capital Management, Llc | 2024-06-30 | 74.6 K | |
| Salem Investment Counselors Inc | 2024-06-30 | 73.9 K | |
| State Street Corp | 2024-06-30 | 72.1 K | |
| Susquehanna International Group, Llp | 2024-06-30 | 71.1 K | |
| Wells Fargo & Co | 2024-06-30 | 59.7 K | |
| Citadel Advisors Llc | 2024-06-30 | 56.6 K | |
| Northern Trust Corp | 2024-09-30 | 54.5 K | |
| Vanguard Group Inc | 2024-09-30 | 1.1 M | |
| Arnhold & S. Bleichroeder Advisers, Llc | 2024-09-30 | 675.2 K |
Icad Historical Income Statement
Icad Stock Against Markets
Icad Corporate Management
| Jonathan Go | Sr. VP of RandD | Profile | |
| Eric Lonnqvist | Chief Officer | Profile | |
| Annette Heroux | Vice Administration | Profile | |
| Stephen Sarno | Interim Officer | Profile | |
| Michelle Strong | Chief Officer | Profile | |
| Brian Testa | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.20) | Revenue Per Share 0.718 | Quarterly Revenue Growth 0.206 | Return On Assets (0.08) | Return On Equity (0.15) |
The market value of icad inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.